Raymond James Financial Services Advisors, Inc. Isoray, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	N/A	950 Added 5.43%	18,450 $12,000
Q3 2023 Oct 24, 2023	SELL	N/A	-1,000 Reduced 5.41%	17,500 $12,000
Q2 2023 Jul 25, 2023	BUY	$0.0 - $0.69 $0 - $690	1,000 Added 5.71%	18,500 $12,000
Q3 2021 Nov 02, 2021	SELL	$0.58 - $0.79 $4,059 - $5,530	-7,000 Reduced 28.57%	17,500 $11,000
Q2 2021 Aug 11, 2021	BUY	$0.75 - $1.15 $1,500 - $2,300	2,000 Added 8.89%	24,500 $20,000
Q1 2021 May 14, 2021	BUY	$0.53 - $2.47 $954 - $4,446	1,800 Added 8.7%	22,500 $25,000
Q4 2020 Feb 12, 2021	SELL	$0.36 - $0.58 $648 - $1,044	-1,800 Reduced 8.0%	20,700 $9,000
Q2 2020 Jul 17, 2020	BUY	$0.47 - $0.86 $1,410 - $2,580	3,000 Added 15.38%	22,500 $12,000
Q1 2020 Apr 21, 2020	BUY	$0.53 - $0.99 $265 - $495	500 Added 2.63%	19,500 $10,000
Q4 2019 Feb 12, 2020	BUY	$0.3 - $0.69 $450 - $1,035	1,500 Added 8.57%	19,000 $12,000
Q3 2018 Nov 14, 2018	SELL	$0.43 - $1.07 $5,375 - $13,375	-12,500 Reduced 41.67%	17,500 $9,000
Q3 2017 Oct 26, 2017	SELL	$0.51 - $0.6 $1,550 - $1,824	-3,040 Reduced 9.2%	30,000 $15,000
Q2 2017 Aug 15, 2017	BUY	N/A	33,040	33,040 $21,000

Others Institutions Holding ISR

# of Institutions

Shares Held

287K

Call Options Held

Put Options Held

View Full List

About Isoray, Inc.

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

More about ISR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account